| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.087 | 0.007 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.099 | 0.008 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.09 | 0.008 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.081 | 0.008 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.009 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.13 | 0.009 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.009 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |